Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2535693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA topoisomerase II as a target of antineoplastic drug therapy

  2004cited by this paper
• Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.

  1988cited by this paper
• Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines.

  1987cited by this paper
• Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.

  1987influential reference
• Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.

  1987cited by this paper
• Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa.

  1986cited by this paper
• Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.

  1986cited by this paper
• Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.

  1986influential reference
• Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.

  1986cited by this paper
• A quantitative decatenation assay for type II topoisomerases.

  1986influential reference
• DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.

  1986cited by this paper
• Mechanistic aspects of DNA topoisomerases.

  1986cited by this paper
• Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target.

  1986cited by this paper
• Bacteriophage P1 Cre-loxP site-specific recombination. Site-specific DNA topoisomerase activity of the Cre recombination protein.

  1986cited by this paper
• Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.

  1986cited by this paper
• Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.

  1986cited by this paper
• Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II.

  1986cited by this paper
• Eukaryotic topoisomerase II. Characterization of enzyme turnover.

  1986cited by this paper
• Comparison of doxorubicin‐induced DNA damage in doxorubicin‐sensitive and ‐resistant P388 murine leukemia cells

  1986cited by this paper
• Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity.

  1986cited by this paper
• DNA topoisomerases.

  1985cited by this paper
• Purification and characterization of a type II DNA topoisomerase from bovine calf thymus.

  1985cited by this paper
• DNA topoisomerases: enzymes that control DNA conformation.

  1985cited by this paper
• DNA topoisomerases as targets for cancer therapy.

  1985influential reference
• Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.

  1985cited by this paper
• Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

  1984cited by this paper
• Replication of kinetoplast DNA maxicircles.

  1984cited by this paper
• Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.

  1984cited by this paper
• Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

  1984cited by this paper
• Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

  1984cited by this paper
• Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

  1984cited by this paper
• Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster.

  1983cited by this paper
• Cleavage of DNA by mammalian DNA topoisomerase II.

  1983influential reference
• DNA topoisomerases--enzymes that catalyse the breaking and rejoining of DNA.

  1983cited by this paper
• Intra- and intermolecular strand transfer by HeLa DNA topoisomerase I.

  1982cited by this paper
• Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases.

  1981cited by this paper
• A homogeneous type II DNA topoisomerase from HeLa cell nuclei.

  1981cited by this paper
• Knotted DNA from bacteriophage capsids.

  1981cited by this paper
• Decatenation of kinetoplast DNA by topoisomerases.

  1980cited by this paper
• ATP-dependent DNA topoisomerase from D. melanogaster reversibly catenates duplex DNA rings

  1980cited by this paper
• Type II DNA topoisomerases: enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break.

  1980cited by this paper
• In vitro catenation and decatenation of DNA and a novel eucaryotic ATP-dependent topoisomerase.

  1980cited by this paper
• Isolation of maxicircle component of kinetoplast DNA from hemoflagellate protozoa.

  1979cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Kinetoplast DNA.

  1979cited by this paper
• X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution.

  1979cited by this paper
• Protein-associated DNA breaks in cells treated with adriamycin or ellipticine.

  1978cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Nature of Col E1 Plasmid Replication in Escherichia coli in the Presence of Chloramphenicol

  1972cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Phytochemical Characterization of Topoisomerase-II Inhibitor from Freshwater Algae Chlorosarcinopsis

  2020cites this paper
• Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer.

  2020cites this paper
• Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer.

  2019cites this paper
• The challenge of drug resistance in cancer treatment: a current overview

  2018cites this paper
• OF NORTH AMERICA New Directions in Breast Cancer Research and Therapeutics

  2017cites this paper
• Topoisomerases: Resistance versus Sensitivity, How Far We Can Go?

  2017cites this paper
• Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism

  2016cites this paper
• Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer

  2016cites this paper
• Erratum to: PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma

  2015cites this paper
• PURIFICATION AND CHARACTERIZATION OF TOPOISOMERASE II INHIBITOR FROM STREPTOMYCES SP

  2015influential citation
• Lipid-albumin nanoassemblies co-loaded with borneol and paclitaxel for intracellular drug delivery to C6 glioma cells with P-gp inhibition and its tumor targeting

  2015cites this paper
• Cytotoxic drugs and their effects on bladder function

  2015cites this paper
• PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma

  2015cites this paper
• Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.

  2015cites this paper
• Purification of GidA protein, a novel topoisomerase II inhibitor produced by Streptomycesflavoviridis

  2014cites this paper
• In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line.

  2014cites this paper
• Small Molecule Therapeutics Combined MET Inhibition and Topoisomerase I Inhibition Block Cell Growth of Small Cell Lung Cancer

  2014cites this paper
• ABC Transporters in Multi-Drug Resistance and ADME-Tox of Small Molecule Tyrosine Kinase Inhibitors

  2014cites this paper
• Efecto del hidroxitirosol sobre la cardiotoxicidad producida por doxorubicina

  2013cites this paper
• The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target

  2013cites this paper
• Formulation Devlopment Of Mesoporous Silica Nanoparticles As An Injectable Delivery System

  2013cites this paper
• Locus α and the Retinoic Acid Receptor α Topoisomerase II Expression of a Fusion Messenger RNA Transcript Encoding Rearrangement in Adriamycin-resistant P388 Leukemia: Gene α Characterization of a DNA Topoisomerase II

  2013cites this paper
• Development of a Tumor‐Specific Photoactivatable Doxorubicin Prodrug

  2013cites this paper
• Influences of “Spasmolytic Powder” on Pgp Expression of Coriaria Lactone-Kindling Drug-Resistant Epileptic Rat Model

  2013cites this paper
• Combined MET Inhibition and Topoisomerase I Inhibition Block Cell Growth of Small Cell Lung Cancer

  2013cites this paper
• Purification of GidA protein, a novel topoisomerase II inhibitor produced by Streptomycesflavoviridis

  2013influential citation
• How do chemotherapeutic agents damage the ovary?

  2012cites this paper
• V-ATPase Inhibitors in Cancer Treatment and Their Implication in Multidrug Resistance in Oral Squamous Cell Carcinoma

  2011cites this paper
• Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance.

  2011cites this paper
• Lack of in vivo cross-resistance with 4′-thio-ara-C against drug-resistant murine P388 and L1210 leukemias

  2011cites this paper
• Cationic submicron emulsions overcome multidrug resistance in SGC7901/VCR cells.

  2011cites this paper
• Anthracyclines and Anthracenediones

  2011cites this paper
• TAT-conjugated nanodiamond for the enhanced delivery of doxorubicin

  2011cites this paper
• Biological markers in breast cancer and acute leukaemia

  2010cites this paper
• Determinación de ATP6V1C1 en muestras de citología exfoliativa de la cavidad oral: implicación en el diagnóstico del carcinoma oral de células escamosas. Un estudio preliminar

  2010cites this paper
• DOXORUBICIN INDUCED CARDIOTOXICITY : POSSIBLE CAUSE AND PREVENTIONS

  2010cites this paper
• Multidrug resistance in oral squamous cell carcinoma: The role of vacuolar ATPases.

  2010cites this paper
• A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIα, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma

  2010cites this paper
• Bayesian Nonparametric Variable Selection as an Exploratory Tool for Finding Genes that Matter

  2010cites this paper
• A nonparametric approach for relevance determination

  2010cites this paper
• Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.

  2009cites this paper
• Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer

  2008cites this paper
• Engineered nanocarriers of doxorubicin: a current update.

  2008cites this paper
• Chapter 49 – Natural and Acquired Resistance to Cancer Therapies

  2008cites this paper
• Characterization of an etoposide-resistant human small-cell lung cancer cell line

  2008cites this paper
• DRUG RESISTANCE IN ACUTE MYELOID LEUKEMIA

  2008cites this paper
• Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.

  2008cites this paper
• Apoptosis induced by ID6105, a new anthracycline (11-hydroxyaclacinomycin X, Hyrubicin), and its anti-tumor effects on experimental tumor models

  2007cites this paper
• Ceramide and Multidrug Resistance

  2007cites this paper
• Topoisomerase IIalpha mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia.

  2007cites this paper
• Molecular Screening for Target Discovery in Cancer

  2006cites this paper
• Bursting on the Scene: How Thalamic Neurons Grab Your Attention

  2006cites this paper
• Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.

  2006cites this paper
• In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin)

  2006cites this paper
• Multidrug Resistant Human Small Cell Lung Carcinoma Cells-aniside in Atypical m-( 9-Acridinylamino ) methanesulfon-′ Topoisomerase II as a Target of VM-26 and 4 Updated

  2006cites this paper
• Multiple drug resistance mechanisms in Imatinib resistant human chronic myeloid leukemia cells.

  2006cites this paper
• Characterization and Mechanism of Resistance Cell Line of Human Non-Small Cell Lung Cancer : Establishment of a Camptothecin Analogue ( CPT-11 )-resistant

  2006cites this paper
• Evidence for a Mutant AlÃ-eleof the Gene for DNA Topoisomerase II in Adriamycin-resistant P 388 Murine Leukemia Cells 1

  2006cites this paper
• TOPOISOMERASE II AND DRUG SENSITIVITY IN HUMAN LUNG CANCER CELLS MATERIALS AND METHODS Cell Lines and Cytotoxicity Assay

  2006cites this paper
• Novobiocin Expressing Multidrug Resistant Tumor Cell Lines by Reversal of Etoposide Resistance in Non-P-Glycoprotein

  2006cites this paper
• Therapeutic Resistance in Leukemia

  2006cites this paper
• The detection of potential drug resistance markers using proteomic technologies

  2006cites this paper
• Maeda in Vitro Multidrug-resistant Chinese Hamster Ovary Cells Low-Molecular-Weight Anticancer Agents on Comparison of the Cytotoxic Effects of the High-and Updated

  2006cites this paper
• Cytotoxicity of a natural anthraquinone (Aloin) against human breast cancer cell lines with and without ErbB-2: Topoisomerase II-alpha coamplification

  2006cites this paper
• Sartorelli and Cross-Resistant to Other Topoisomerase II-targeted Drugs Monomyelocytic Leukemia Cell Line Resistant to Novobiocin + Development and Characterization of a WEHI-3 B D Updated

  2006cites this paper
• High-Level Resistance to Bisdioxopiperazines Catalytic Inhibitor ICRF-159 : A Tyr 49 Phe Mutation Confers Chinese Hamster Ovary Cells Resistant to the Topoisomerase II Updated

  2006cites this paper
• Molecular Cloning and Characterization of the Complementary DNA for the Mr 85 , 000 Protein Overexpressed in Adriamycin-resistant Human Tumor Cells 1

  2006cites this paper
• Lung Carcinoma Cell Line Cleavage Activity in an Adriamycin-resistant Human Small Cell Reduced DNA Topoisomerase II Activity and Drug-induced DNA

  2006cites this paper
• Cancer Cells to Anticancer Drugs P-Glycoprotein and Resensitizes Multidrug-Resistant Breast Glucosylceramide Synthase Blockade Down-Regulates

  2005cites this paper
• Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.

  2005cites this paper
• Study of novel dual topoisomerase poisons as potential anti-cancer drugs

  2005cites this paper
• Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia

  2005cites this paper
• Adriamycin uptake and metabolism in organotypic culture of A 549 human adenocarcinoma cells according to the exposure time

  2005cites this paper
• In vivo adriamycin-induced apoptosis in peritoneal murine macrophages: partial participation of a caspase cascade.

  2004cites this paper
• Characterization of an etoposide-resistant human ovarian cancer cell line

  2004cites this paper
• Phosphorylation of DNA Topoisomerase I by the c-Abl Tyrosine Kinase Confers Camptothecin Sensitivity*

  2004cites this paper
• Overexpression of Ssl2p confers resistance to adriamycin and actinomycin D in Saccharomyces cerevisiae.

  2004cites this paper
• Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target

  2004cites this paper
• Topoisomerase expression in cancer cell lines and clinical samples

  2004cites this paper
• 3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) triggers apoptosis by DNA double-strand breaks caused by inhibition of topoisomerase I.

  2004cites this paper
• Resistance to cytostatic drugs at the cellular level

  2004cites this paper
• Topoisomerase IIα expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome

  2004cites this paper
• Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.

  2004cites this paper
• Topoisomerase II in multiple drug resistance

  2004cites this paper
• Doxorubicin inhibits human DNA topoisomerase I

  2004cites this paper
• Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin

  2004cites this paper
• Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice

  2004cites this paper
• Modulation of c-Kit/SCF pathway leads to alterations in topoisomerase-I activity in small cell lung cancer.

  2004cites this paper
• Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance

  2004cites this paper
• Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.

  2003cites this paper
• The Topoisomerase IIa Expression Correlates with Survival in Patients with Advanced Hodgkin’s

  2003cites this paper
• Ceramide Signaling under Oxidative Stress

  2003cites this paper
• Drug Resistance and Its Clinical Circumvention

  2003cites this paper
• Quinolones and Eukaryotic Topoisomerases

  2003cites this paper
• Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid.

  2003cites this paper
• Clinical Relevance of P-Glycoprotein in Drug Therapy

  2003cites this paper
• The role of Galectin-3 and Survivin in invasion and drug resistance in human cancer

  2003cites this paper
• Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia

  2003cites this paper
• Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells

  2002cites this paper
• An investigation of the role of the ErbB receptor family in chemotherapeutic drug resistance and invasion in human breast cancer

  2002cites this paper